April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
HLA markers of cold medicine-related Stevens-Johnson syndrome with severe mucosal involvements in the Japanese
Author Affiliations & Notes
  • Mayumi Ueta
    Ophthalmology, Kyoto Prefectural Univ of Med, Doshisha, Uji, Japan
    Research Center for Inflammation and Regenerative Medicine,, Faculty of Life and Medical Sciences, Doshisha University, kyotanabe, Japan
  • Chie Sotozono
    Ophthalmology, Kyoto Prefectural Univ of Med, Doshisha, Uji, Japan
  • Shigeru Kinoshita
    Ophthalmology, Kyoto Prefectural Univ of Med, Doshisha, Uji, Japan
  • Footnotes
    Commercial Relationships Mayumi Ueta, None; Chie Sotozono, None; Shigeru Kinoshita, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4064. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mayumi Ueta, Chie Sotozono, Shigeru Kinoshita; HLA markers of cold medicine-related Stevens-Johnson syndrome with severe mucosal involvements in the Japanese. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4064.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Stevens-Johnson syndrome (SJS) and its severe variant, toxic epidermal necrolysis (TEN), are acute inflammatory vesiculobullous reactions of the skin and mucous membranes of, for example, the ocular surface, oral cavity, and genitals. They are rare but often associated with inciting drugs. Cold medicines including non-steroidal anti-inflammatory drugs (NSAIDs) and multi-ingredient cold medications are reported to be important inciting drugs. We investigated the association between HLA genotypes and cold medicine-related SJS/TEN (CM-SJS/TEN) with severe mucosal involvement such as severe ocular surface complications (SOC). We also investigated the association between HLA genotypes and acetaminophen-related SJS/TEN in patients with CM-SJS/TEN with SOC.

Methods: Japanese SJS/TEN patients consist of 131 CM-SJS/TEN patients, they were among the 162 SJS/TEN patients with SOC. The diagnosis of SJS/TEN with SOC was based on a confirmed history of acute-onset high fever, serious mucocutaneous illness with skin eruptions, and the involvement of at least 2 mucosal sites including the oral cavity and ocular surface. We analyzed HLA-A, -B, and -C of 131 CM-SJS/TEN patients and 220 Japanese controls.

Results: Among the 162 SJS/TEN patients 131 (80.9%) had taken cold medicines such as NSAIDs and multi-ingredient cold medications several days before disease onset; they were classified as CM-SJS/TEN patients. While the specific drugs were not named by all 131 patients, 59 (45.0%) were known to have taken medicines containing acetaminophen. HLA-A*02:06 was strongly associated with CM-SJS/TEN with SOC(carrier frequency: p=3.9X10-12,Pc=7.7X10-11,OR=5.7), and the odds ratio was highest for acetaminophen-related SJS/TEN with SOC(carrier frequency: p=1.4X10-10,Pc=2.7X10-9,OR=7.0).

Conclusions: Elucidating the predisposition to drug-induced severe cutaneous adverse reactions might make it possible to prevent SJS/TEN with SOC with avoiding the risk drug from the person having the predisposition.

Keywords: 474 conjunctiva • 486 cornea: tears/tear film/dry eye • 539 genetics  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×